Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib significantly regrows hair in teens with severe alopecia areata.

Baricitinib shows promise for severe alopecia areata but isn't a cure and has side effects.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

Baricitinib effectively improved skin and hair conditions in a patient with alopecia areata and atopic dermatitis.

Monoolein-alginate beads help heal wounds by controlling moisture and effectively delivering adenosine to the skin.

Granulomatous Alopecia Areata is rare and may be caused by hair antigens or follicle destruction.

Abatacept may help some people with alopecia areata regrow hair.

Marine macroalgae contain compounds that can improve skin health and have cosmetic benefits.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

Gluconolactone products can significantly reduce skin scaling in golden retrievers with ARCI.

Androgen receptor activity blocks Wnt/β-catenin signaling, affecting hair growth and skin cell balance.

A new mix of anthralin and calcipotriene might help treat severe hair loss.

Linoleic acid and magnesium are key in alopecia areata progression, and tofacitinib can help by affecting their pathway.

α-Ketoglutaric acid improves hair growth, rabbit performance, and antioxidant levels.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.

Ritlecitinib is effective for long-term treatment of severe alopecia areata.

New drugs, baricitinib and ritlecitinib, are effective for severe alopecia areata.

The study developed a mouse model for Alopecia Areata that responds to treatment, useful for future research.

ARL15 is important for fat cell development and the release of the hormone adiponectin.

The androgen receptor's shape-changing ability helps it function but can lead to cancer treatment resistance.

Targeting amphiregulin may improve treatment for fibrosis and cancer.

Improving blood vessel health and controlling uric acid may help manage alopecia areata.

Baricitinib is effective and safe for treating severe alopecia areata.

Linoleic acid and magnesium are key in alopecia areata progression, and tofacitinib can help by affecting their pathway.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Leflunomide and anthralin may effectively treat severe alopecia areata.